NEOPLASM study: Real-life use of lacosamide in patients with brain tumor-related epilepsy

•There are a lack of clinical trial data on the most effective AEDs for treating BTRE.•Six months of lacosamide treatment led to a 30% seizure-free rate.•There was a ≥50% reduction in seizure number in >66% of patients.•Most of the AEs reported (by 41.9% of patients) were mild-to-moderate in severity.•The most common AEs were somnolence/fatigue and dizziness.